Universität zu Köln

Hohmann, C., Baldus, S. and Pfister, R. (2019). Curing cancer and protecting the heart. Challenges in cardiooncology in the era of modern tumor treatment. Herz, 44 (2). S. 175 - 189. MUNICH: URBAN & VOGEL. ISSN 1615-6692

Full text not available from this repository.

Abstract

Recent advances in the medical oncological treatment options for cancer have led to a clear improvement in the survival rate worldwide; however, many of the recently developed new drugs are directly or indirectly associated with cardiovascular side effects. Cardiovascular diseases are already the most frequent non-cancerous cause of death in tumor patients. Prevention, early detection of these complications, correct management and timely initiation of specific cardiac medical treatment are the key for an improvement of the cardiovascular prognosis. This article provides an overview and comprehensive summary of the possible cardiotoxic side effects of important oncological therapies and offers possible practical strategies with respect to risk stratification, cardiological follow-up care and management approaches for chemotherapy-induced left ventricular dysfunction

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Hohmann, C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Baldus, S. UNSPECIFIED UNSPECIFIED UNSPECIFIED Pfister, R. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-152637
DOI:	10.1007/s00059-019-4787-6
Journal or Publication Title:	Herz
Volume:	44
Number:	2
Page Range:	S. 175 - 189
Date:	2019
Publisher:	URBAN & VOGEL
Place of Publication:	MUNICH
ISSN:	1615-6692
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language TRASTUZUMAB-RELATED CARDIOTOXICITY; CARDIOVASCULAR COMPLICATIONS; EUROPEAN-SOCIETY; CHILDHOOD-CANCER; CO-MORBIDITIES; FAILURE; THERAPY; DOXORUBICIN; RISK; RECOMMENDATIONS Multiple languages Cardiac & Cardiovascular Systems Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/15263